Scientific Sessions 2025  /  Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI  /  Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care
Logo

American Heart Association

  43
  0

Final ID:

Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care

  • Rymer, Jennifer  ( Duke , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Jennifer Rymer: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Frontline Pharmaco-Tactics: Optimizing Pre-Hospital and Early In-Hospital Medication in STEMI

Cohen Mauricio, Tarantini Giuseppe

Beyond Reperfusion: Cardiomyocyte Regeneration in AMI – Hype or Hope?

Pompilio Giulio, Janssens Stefan

More abstracts from these authors:
The Role of Implementation Science and Pragmatic Trials: Adapting to patient needs

Minc Samantha, Rymer Jennifer, Weissler E.

How Artificial Intelligence (AI) can help address disparities in vascular care.

Ross Elsie, Rymer Jennifer

You have to be authorized to contact abstract author. Please, Login
Not Available